PeterBruceBittermanMD

Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease

Professor, Medicine, University of Minnesota Medical School

Dr. Bitterman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
University of Minnesota Medical Center
Minneapolis, MN 55455
Phone+1 612-624-0999

Clinical Center at the National Institutes of HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1978 - 1985
University of ChicagoResidency, Internal Medicine, 1976 - 1978
Yale School of MedicineClass of 1976

Elected Member Association of American Physicians, 2000
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Elected Member The American Society for Clinical Investigation, 1994

PubMed

Tumor suppressors RBL1 and PTEN are epigenetically silenced in IPF mesenchymal progenitor cells by a CD44/Brg1/PRMT5 regulatory complex.
Libang Yang, Hong Xia, Karen Smith, Adam J Gilbertsen, Aiham H Jbeli
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2024-12-01
Brg1/PRMT5 nuclear complex epigenetically regulates FOXO1 in IPF mesenchymal progenitor cells.
Aiham H Jbeli, Libang Yang, Hong Xia, Adam J Gilbertsen, Peter B Bitterman
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2024-03-01
6 citations
IL-8 concurrently promotes idiopathic pulmonary fibrosis mesenchymal progenitor cell senescence and PD-L1 expression enabling escape from immune cell surveillance.
Libang Yang, Hong Xia, Adam Gilbertsen, Karen Smith, Emil Racila
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2023-06-01

ROLE OF FIBROTIC EXTRACELLULAR MATRIX IN GENERATING THE IPF FIBROBLASTNIH/NHLBI2014–2018
Translational Control Of The Fibroblast Phenotype In IPFNational Heart, Lung, And Blood Institute2009–2012
Translational Control In IPFNational Heart, Lung, And Blood Institute2008–2011
Translational State Assay For Human SamplesNational Center For Research Resources2008–2010
Antifibrotic Drug Discovery In Acute Lung InjuryNational Heart, Lung, And Blood Institute2004–2007
Molecular Targets For Drug Discovery In IPFNational Heart, Lung, And Blood Institute2003–2006
SCOR In Acute Lung InjuryNational Heart, Lung, And Blood Institute1994–2003
Translational Repressors As Therapy For OBNational Institute Of Allergy And Infectious Diseases2001–2002
Translational Control Of Fibroblast ViabilityNational Heart, Lung, And Blood Institute1999–2002
Training In Lung ScienceNational Heart, Lung, And Blood Institute1999–2002
Transgenic Murine Model Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute1996–1999
Role Of Apoptosis In Lung RepairNational Heart, Lung, And Blood Institute1996–1998
Training-Pulmonary Cell &Molecular Biology &PhysiologyNational Heart, Lung, And Blood Institute1994–1998
Mesenchymal Cell Subpopulations In Acute Lung FibrosisNational Heart, Lung, And Blood Institute1987–1991